Advertisement

Rheumaderm pp 115-125 | Cite as

Cutaneous Necrotizing Vasculitis

Relation to Systemic Disease
  • Torello M. Lotti
  • C. Comacchi
  • I. Ghersetich
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 455)

Abstract

Cutaneous necrotizing vasculitis (CNV) is a complex multisystem disease generally involving the skin and mucous membranes, often accompanied by renal, gastrointestinal, pericardial, neurological, and articular signs and symptoms. CNV may be idiopatical or occur in association with a drug, infection, or underlyng disease.

CNV has been shown in patients with chronic infections (viral, bacterial, protozoa, helminthic), serum sickness, a variety of collagen vascular diseases (systemic lupus erythematous, Sjögren’s syndrome, rheumatoid arthritis, Behçet’s disease) hyperglobulinemic states, cryoglobulinemia, bowel bypass syndrome, ulcerative colitis, cystic fibrosis, primary biliary cirrhosis and HIV infection. Association with malignancies is not frequent. Lympho- proliferative disorders (Hodgkin’s disease, mycosis fungoides, lymphosarcoma, adult T-cell leukemia, multiple mieloma) and solid tumors (lung cancer, colon carcinoma, renal, prostate, head and neck cancer and breast cancer) may be associated with CNV Whenever possible, treatment is directed at the elimination of the cause. In other cases after adequate laboratory screening local and systemic therapy are recommended.

Keywords

Primary Biliary Cirrhosis Mycosis Fungoides Systemic Lupus Erythematous Serum Sickness Leukocytoclastic Vasculitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lotti T, Comacchi C, Ghersetich I. Cutaneous necrotizing vasculitis. Int J Dermatol 35: 457–474. 1996.PubMedCrossRefGoogle Scholar
  2. 2.
    Ryan TJ. Cutaneous vasculitis. In: Rook A, et al, eds. Textbook of Dermatology. Oxford: Blackwell Sc Publ, 1893–1961. 1992.Google Scholar
  3. 3.
    Comacchi C, Ghersetich I, Lotti T. La vasculite necrotizzante cutanea. G Ital Dermatol Venereol 1998. In press.Google Scholar
  4. 4.
    Lotti T, Ghersetich I, Comacchi C, Panconesi E. Purpuras and related conditions. J Eur Acad Dermatol Venereol, 7–25. 1996Google Scholar
  5. 5.
    Lotti T, Ghersetich I, Comacchi C, Jorizzo JL. Cutaneous small vessel vasculitis. Am Acad Dermatol 1998. In press.Google Scholar
  6. 6.
    Jorizzo JL, Solomon AR, Zanolli MD, et al. Neutrophilic vascular reactions. J Am Acad Dermatol. 19(6): 983–1005. 1988PubMedCrossRefGoogle Scholar
  7. 7.
    Soter NA, Wolff SM. Necrotizing vasculitis. In: Fitzpatrick TB, et al, eds. Dermatology in General Medicine. New York: McGraw-Hill Book Company. 1300–1312. 1987Google Scholar
  8. 8.
    Soter NA, Mihm MC Jr, Gigli I, et al. Two distinct cellular patterns in cutaneous necrotizing angiitis. J Invest Dermatol. 66: 344–350. 1976PubMedCrossRefGoogle Scholar
  9. 9.
    Ghersetich I, Campanile G, Comacchi C, et al. Cutaneous necrotizing vasculitis: are there indeed two distinct histopathological entities? Abstract Book “14th Colloquium of the International Society of Dermopathology”, Siena, 26 June–1 July 1993. 86.Google Scholar
  10. 10.
    Ghersetich I, Campanile G, Comacchi C, Lotti T. Immunohistochemical and ultrastructural aspects of leukocytoclastic cutaneous necrotizing vasculitis (CNV). J Invest Dermatol 100(4): 545. 1993.Google Scholar
  11. 11.
    Ghersetich I, Comacchi C, Lotti T. La vasculite cutanée nécrosante: l’infiltrat cellulaire et l’expression de quelques récepteurs de molécules d’adhesion. Nouv Dermatol. 11(10): 852–853. 1992Google Scholar
  12. 12.
    Ghersetich I, Campanile G, Comacchi C, Lotti T. The cell-mediated pathway in the pathogenesis of the leukocytoclastic form of cutaneous necrotizing vasculitis.Abstract Book “Dermatology 2000”, Vienna 18–21 May 1993. 271.Google Scholar
  13. 13.
    Comacchi C, Ghersetich I, Lotti T. Una cellula ememergente in dermatologia: il linfocita T gamma/delta. G Ital Dermatol Venereol. 128(4): 133–40. 1993Google Scholar
  14. 14.
    Campanile G, Comacchi C, Ghersetich I, Lotti T. Gamma/delta T lymphocytes in cutaneous necrotizing vasculitis. Int Angiol 14(2): 119–124. 1995.Google Scholar
  15. 15.
    Ghersetich I, Campanile G, Comacchi C, Lotti T. Gamma/delta TCR lymphocytes in cutaneous necrotizing vasculitis (CNV): a clue to the infective etiology. J Invest Dermatol. 100(4): 465. 1993Google Scholar
  16. 16.
    Parish WE. Studies on vasculitis. Immunoglobulins, B1C, C-reactive protein, and bacterial antigens in cutaneous vasculitis lesions. Clin Allergy. 1: 97–109. 1971PubMedCrossRefGoogle Scholar
  17. 17.
    Gower RG. Small vessel vasculitis caused by hepatitis B virus immune complexes: small vessel vasculitis and HBsAG. J Allergy Clin Immunol. 62: 222. 1978.Google Scholar
  18. 18.
    Thorne EG, Gower R, Claman HN. Hepatitis B surface antigen and leukocytoclastic vasculitis. J Invest Dermatol. 68: 243–247. 1977Google Scholar
  19. 19.
    Heart-Holmes M, Zahradka S, Baethge BA, et al. Leukocytoclastic vasculitis associated with hepatitis C. Am J Med 90: 765–766. 1991.Google Scholar
  20. 20.
    Dan M, Yaniv R. Cholestatic hepatitis, cutaneous vasculitis and vascular deposits of immunoglobulin M and complement associated with hepatitis A virus infection. Am J Med 89: 103–104. 1990.PubMedCrossRefGoogle Scholar
  21. 21.
    Mosovich B, Biton A, Avinoach I. Vasculitis with cutaneous necrosis induced by oral contraceptive. Harefuah. 120: 451–453. 1991PubMedGoogle Scholar
  22. 22.
    Patel A, Prussick R, Buchanan WW. Serum sickness-like illness and leukocytoclastic vasculitis after intravenous streptokinase. J Am Acad Dermatol 1991. 24: 652–653.PubMedCrossRefGoogle Scholar
  23. 23.
    Parker CW. Drug allergy. In: Parker CW, ed. Clinical Immunology. Philadelphia: Saunders WB Company, 1219–1260. 1980.Google Scholar
  24. 24.
    Berman BA, Ross RN. Acute serum sickness. Cutis 32: 420–422. 1983PubMedGoogle Scholar
  25. 25.
    Vial T, Laine V, Delcombel M, et al. Vasculitis after anti-influenza vaccination. Report of 5 cases. Therapie 45: 509–512. 1990.Google Scholar
  26. 26.
    Drago F, Arditi M, Rebora A. Tamoxifen and purpuric vasculitis. Ann Intern Med 112: 965–966. 1990.PubMedGoogle Scholar
  27. 27.
    Hodge SJ, Callen JP, Ekenstom E. Cutaneous leukocytoclastic vasculitis: correlation of histopathological changes with clinical severity and course. J Cutan Pathol. 14: 279–284. 1987PubMedCrossRefGoogle Scholar
  28. 28.
    Lakhanpal S, Conn DL, Lie JT. Clinical and prognostic significance of vasculitis as an early manifestation of connective tissue disease syndrome. Ann Intern Med 101: 743–748. 1984.PubMedGoogle Scholar
  29. 29.
    Estes D, Christian DL. The natural history of systemic lupus erythematous by prospective analysis. Medicine. 50: 85–95. 1971PubMedCrossRefGoogle Scholar
  30. 30.
    Dubois EL, Wallace DJ. Clinical and laboratory manifestations of systemic lupus erythematosus. In: Wallace DJ, et al, eds. Lupus erythematosus. Philadelphia: Lea and Febriger. 317–449. 1987Google Scholar
  31. 31.
    Chevalier X, Belmatoug N, Kahn MF. Seronegative leukocytoclastic vasculitis preceding the onset of disseminated systemic lupus erythematosus. Rev Rhum Mal Osteoartic 57: 779–783. 1990.PubMedGoogle Scholar
  32. 32.
    O’ Loughlin, Schroeter AL, Jordan RE. Chronic urticaria — like lesions in systemic lupus erythematosus. Arch Dermatol. 114: 879–883. 1978CrossRefGoogle Scholar
  33. 33.
    Christian CL, Sergent JJ. Vasculitis syndromes: clinical and experimental models. Am J Med. 61: 385–392. 1976PubMedCrossRefGoogle Scholar
  34. 34.
    Lawley TJ, Moutsopoulos HM, Katz SI, et al. Demonstration of circulating immune complexes in Sjogren’s syndrome. J Immunol. 123: 1382–1387. 1979PubMedGoogle Scholar
  35. 35.
    Moutsopoulos HM, Chused TM, Mann DL, et al. Sjogren’s syndrome (sicca syndrome): current issues. Ann Intern Med. 92: 212–226. 1980PubMedGoogle Scholar
  36. 36.
    Talal N, Moutsopoulos HM, Kassan SS. Sjögren Syndrome. Clinical and immunological aspects. Berlin: Springer, 1987.Google Scholar
  37. 37.
    Gray RG, Poppo MJ. Necrotizing vasculitis as the initial manifestation of rheumatoid arthritis. J Rheumatol 10: 326–328. 1983PubMedGoogle Scholar
  38. 38.
    Nishikawa JA. Are leg ulcers in rheumatoid arthritis due to vasculitis? Eur J Rheum Inflam. 6: 288–290. 1983Google Scholar
  39. 39.
    Jorizzo JL, Daniels JC. Dermatologic conditions reported in patients with rheumatoid arthritis. J Am Acad Dermatol. 8: 439–457. 1983PubMedCrossRefGoogle Scholar
  40. 40.
    Levinsky RJ, Lehner J. Circulating soluble immune complexes in recurrent oral ulceration and Behçet’ syndrome. Clin Exp Immunol. 32: 193–198. 1978PubMedGoogle Scholar
  41. 41.
    Valesini G, Picardo M, Pastare R et al. Circulating immune complexes in Behçet’s syndrome: purification, characterization and cross reactivity studies. Clin Exp Immunol. 44: 522–527. 1981PubMedGoogle Scholar
  42. 42.
    Jorizzo J. Behçet’s disease. An update based on the 1985 international conference in London. Arch Dermatol. 122: 556–558. 1986PubMedCrossRefGoogle Scholar
  43. 43.
    Waldenström J. Dysproteinemias. In: Fitzpatrick TB, et al, eds. Dermatology in General Medicine. New York: McGraw-Hill Book Company. 1650–1654. 1987Google Scholar
  44. 44.
    Braun-Falco O, Plewig G, Wolff HH, et al. Dermatology. Berlin Heidelberg: Springer-Verlag. 877–878. 1991Google Scholar
  45. 45.
    Boom BW, Brand A, Bouwes-Bavink JN, et al. Severe leukocytoclastic vasculitis of the skin in a patient with essential mixed cryoglobulinemia treated with high-dose gamma-globulins intravenously. Arch Dermatol. 124: 1550–1553. 1988PubMedCrossRefGoogle Scholar
  46. 46.
    Bronet JC, Clauvel JP, Danon F, et al. Biologic and clinical significance of cryoglobulinemia: a report of 86 cases. Am J Med. 57: 775–788. 1974CrossRefGoogle Scholar
  47. 47.
    Popp JW Jr, Dienstag JL, Wands JR, et al. Essential mixed cryoglobulinemia without evidence for hepatitis B virus infection. Ann Intern Med. 92: 379–383. 1980PubMedGoogle Scholar
  48. 48.
    Ely PH. The bowel bypass syndrome: a response to bacterial peptidoglycans. J Am Acad Dermatol. 2: 473–487. 1980PubMedCrossRefGoogle Scholar
  49. 49.
    Dicken CH, Seehafter JR. Bowel bypass syndrome. Arch Dermatol. 115: 837–839. 1979PubMedCrossRefGoogle Scholar
  50. 50.
    Gilliam JN, Smiley JD. Cutaneous necrotizing vasculitis and related disorders. Ann Allergy. 37: 328–339. 1976PubMedGoogle Scholar
  51. 51.
    Webb AK. Management problems of the adult with cystic fibrosis. Schweiz Med Wochenschr. 121: 110–114. 1991PubMedGoogle Scholar
  52. 52.
    Soter NA et al. Cutaneous necrotizing venulitis in patients with cystic fibrosis. J Pediatr. 95: 197. 1979PubMedCrossRefGoogle Scholar
  53. 53.
    Weimer Ce Jr, Sahn EE. Follicular accentuation of leukocytoclastic vasculitis in an HIV-seropositive man. Report of a case and review of the literature. J Am Acad Dermatol. 24: 898–902. 1991PubMedCrossRefGoogle Scholar
  54. 54.
    Cockerell CJ. Noninfectious inflammatory skin diseases in HIV-infected individuals. Dermatol Clin. 9: 531–541. 1991PubMedGoogle Scholar
  55. 55.
    Barlow RJ, Schulz EJ. Necrotizing folliculitis in AIDS-related complex. Br J Dermatol. 116: 581–584. 1987PubMedCrossRefGoogle Scholar
  56. 56.
    Kurzrock R, Cohen PR. Vasculitis and Cancer. Clinics in Dermatology. 11; 175–187. 1993PubMedCrossRefGoogle Scholar
  57. 57.
    Greer JM, Lousley S, Edwards NL, et al. Vasculitis associated with malignancy. Medicine. 67: 220–229. 1988PubMedCrossRefGoogle Scholar
  58. 58.
    Nevin M, Armus S, Wolff M, et al. Cutaneous T-cell lymphoma in association with leukocytoclastic vasculitis. Int J Dermatol. 30: 443–444. 1991PubMedCrossRefGoogle Scholar
  59. 59.
    Kesseler ME, Slater DN. Cutaneous vasculitis: A presenting feature in Hodgkin’s disease. J R Soc Med. 79: 485–486. 1986PubMedGoogle Scholar
  60. 60.
    Sams WM Jr, Harville DD, Winkelmann RK. Necrotizing vasculitis associated with lethal reticuloen-dothelial diseases. Br J Dermatol. 80: 555–560. 1968PubMedCrossRefGoogle Scholar
  61. 61.
    Kois JM, Sexton FM, Lookingbill DP. Cutaneous manifestations of multiple myeloma. Arch Dermatol. 127: 69–74. 1991PubMedCrossRefGoogle Scholar
  62. 62.
    Beylot J, Malou M, Doutre MS, et al. Leukocytoclastic vasculitis and malignant hematologic diseases (12 cases). Rev Med Interne. 10: 509–514. 1989PubMedCrossRefGoogle Scholar
  63. 63.
    Callen JR Cutaneous leukocytoclastic vasculitis in a patient with an adenocarcinoma of the colon. J Rheumatol.14: 386–389. 1987PubMedGoogle Scholar
  64. 64.
    Lewis JE. Urticarial vasculitis occurring in association with visceral malignancy. Acta Derm Venereol (Stockh). 70: 344–345. 1990Google Scholar
  65. 65.
    Saulsbury FT. Henoch-Schöenlein purpura. Pediatr Dermatol. 1: 195–201. 1984PubMedCrossRefGoogle Scholar
  66. 66.
    Palier AS. Disorders of the immune system. In: Schachner LA, et al, eds. Pediatric Dermatology. New York: Churchill Livingstone Inc. 93–137. 1988Google Scholar
  67. 67.
    Heng MCY. Henoch-Schöenlein purpura. Br J Dermatol. 112: 235–240. 1985PubMedCrossRefGoogle Scholar
  68. 68.
    VanHale HM, Gibson LE, Schroeter AL. Henoch-Schöelein vasculitis: direct immunefluorescence study of uninvolved skin. J Am Acad Dermatol. 15: 665–670. 1986CrossRefGoogle Scholar
  69. 69.
    Stevenson JA, Leong LA, Cohen AH, et al. Henoch-Schönleinpurpura. Simultaneous demonstration of IgA deposits in involved skin, intestine, and kidney. Arch Pathol 106: 192–195. 1982Google Scholar
  70. 70.
    Soter NA. Chronic urticaria as a manifestation of necrotizing venulitis. N Engl J Med. 296: 1440–1442. 1977PubMedCrossRefGoogle Scholar
  71. 71.
    Wanderer AA, Nuss DD, Thormey AD, et al. Urticarial leukocytoclastic vasculitis with cold urticarial: report of a case and review of the literature. Arch Dermatol. 119: 145–151. 1983PubMedCrossRefGoogle Scholar
  72. 72.
    Monroe EF. Urticarial vasculitis: an update review. J Am Acad Dermatol. 5: 88–95. 1981PubMedCrossRefGoogle Scholar
  73. 73.
    Callen JP, Kalbfleisch S. Urticarial vasculitis: a report of nine cases and review of the literature. Br J Dermatol. 107: 87–94. 1982PubMedCrossRefGoogle Scholar
  74. 74.
    Scherer R. Urtikariavaskulitis. Hautarzt. 36(suppl VII): 48–50. 1985Google Scholar
  75. 75.
    Borradori L et al. Urticarial vasculitis associated with monoclonal IgM gammopathy: Schnitzler’s syndrome. Br J Dermatol 123: 113–118. 1990.PubMedCrossRefGoogle Scholar
  76. 76.
    Grassegger A, Greil R, Feichtinger J, et al. Urticarial vasculitis as a symptom of Muckle-Wells syndrome? Hautarzt. 42: 116–119. 1991PubMedGoogle Scholar
  77. 77.
    Cream JJ, Leven GM, Calnan CD. Erythema elevatum diutinum. Br J Dermatol. 84: 393–399. 1971PubMedCrossRefGoogle Scholar
  78. 78.
    Le Boit PE, Yen TSB, Wintroub B. The evolution of lesions in erythema elevatum diutinum. Am J Dermatopathol. 8: 392–402. 1986CrossRefGoogle Scholar
  79. 79.
    Wolff HH, Scherer R, Maciejewski W, et al. Erythema elevatum diutinum. II. Immunoelectromicroscopical study of leukocytoclastic vasculitis within the intracutaneous test reaction induced by streptococcal antigen. Arch Dermatol Res. 261: 17–26. 1978Google Scholar
  80. 80.
    Feldacker M, Hines EA, Kierland RR. Livedo reticularis with summer ulcerations. Arch Dermatol Syphilol. 72: 31–37. 1955CrossRefGoogle Scholar
  81. 81.
    Marsch WC, Muckelmann R. Generalized racemose livedo with cerebrovascular lesions (Sneddon syndrome): an occlusive arteriolopathy due to proliferation and migration of medial smooth muscle cells. Br J Dermatol. 112: 703–708. 1985PubMedCrossRefGoogle Scholar
  82. 82.
    Braun Falco O, Plewig G, Wolff HH, et al. Dermatology. Berlin: Springer-Verlag. 637–638. 1991Google Scholar
  83. 83.
    Diaz-Perez J, Winkelmann RK. Cutaneous periarteritis nodosa. Arch Dermatol. 110: 407–412. 1974PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Torello M. Lotti
    • 1
  • C. Comacchi
    • 1
  • I. Ghersetich
    • 1
  1. 1.Department of DermatologyUniversity of FlorenceFlorenceItaly

Personalised recommendations